MedPath

Brief Shame Intervention Study

Not Applicable
Completed
Conditions
Social Anxiety Disorder
Shame
Interventions
Behavioral: Shame Intervention
Registration Number
NCT03463356
Lead Sponsor
Miami University
Brief Summary

The current project will develop and test a brief 2-session shame intervention in individuals diagnosed with social anxiety disorder (SAD). Using a non-concurrent multiple baseline design, the investigators will determine whether the brief shame intervention leads to reductions in trait self-reported shame and state shame in response to an in vivo stressor task. The investigators will also evaluate the effect of changes in shame on trait SAD symptoms.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
14
Inclusion Criteria

-≥ 18 years old

  • fluent in English, in terms of verbal and written competence
  • meet diagnostic criteria for social anxiety disorder (as assessed by the Diagnostic Interview for Anxiety, Mood, and OCD and Related Neuropsychiatric Disorders; Tolin et al., 2016)
  • have elevated levels of shame (i.e., score 1 SD above the Test of Self-Conscious Affect-3 [TOSCA-3] means reported by an unselected undergraduate sample [M = 33.62, SD = 8.64])
  • endorse a desire to decrease their levels of shame and/or social anxiety.
Exclusion Criteria
  • currently receiving cognitive-behavioral therapy specifically for social anxiety or shame
  • have begun taking or had a change in dosage of psychotropic medication in the past six weeks
  • do not achieve baseline stability

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Shame InterventionShame InterventionParticipants will complete a two shame intervention sessions approximately one week apart.
Primary Outcome Measures
NameTimeMethod
Change in Test of Self-Conscious Affect-3-Short FormParticipants indicate likelihood of responses to scenarios. Administered at B1-B5 and T1-T5. B1-B5 occur ~1 week apart. T1 occurs ~1 week after the final baseline. T1-T4 each occur within ~2 weeks of each other. T5 occuring ~1 month after T4.

Self-report of how likely an individual is to react to 11 scenarios with shame responses

Secondary Outcome Measures
NameTimeMethod
Change in State Shame and Guilt MeasureParticipants report on symptoms experienced during the speech task. Administered at T1 and T4. T4 occurs within ~6 weeks after T1.

Self-report of levels of shame experienced during the speech task

Change in Brief State Anxiety MeasureParticipants report on symptoms experienced during the speech task. Administered at T1 and T4. T4 occurs within ~6 weeks after T1.

Self-report of levels of anxiety experienced during the speech task

Change in Liebowitz Social Anxiety-Self-ReportParticipants report on symptoms during the past week. Administered at T1-T5. T1-T4 each occur within ~2 weeks of each other. T5 occurs ~1 month after T4.

Self-report of social anxiety symptoms

Change in Shame InventoryParticipants report on typical experience of symptoms. Administered at T1, T4, and T5. T4 occurs within ~6 weeks after T1. T5 occurs ~1 month after T4.

Self-report of shame symptoms

Trial Locations

Locations (1)

Anxiety Cognition and Emotion Laboratory

🇺🇸

Oxford, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath